Individual Study / COLU

Genomic data with clinical outcome data from routine practice data from The Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA

Genomic data with clinical outcome data from routine practice data from The Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA

Initiatives -
Columbia University Irving Medical Center uses the Illumina TruSeq Amplicon – Cancer Panel (TSACP) to detect known cancer hotspots. * Provide oversight and infrastructure for the development and maintenance of cancer-related clinical databases and biobanks for collection of data and biospecimens. * Enable linkage to clinical data and tumor registry data through a secure portal. * To procure and maintain a repository of human biological samples, clinical data and epidemiologic data for distribution to investigators, while also protecting the confidentiality of individuals donating to the repository in the course of their medical care and/or research participation.
Visit COLU

Members

Download
Investigators Contacts
  • Director Katherine Crew
    Columbia University- Herbert Irving Comprehensive Cancer Center

Design

Study design
Patients' cohort

Recruitment

Sources of Recruitment
  • Individuals

Number of participants

Number of participants
Number of participants with biosamples

Access

Availability of data and biosamples

Data
Biosamples
Other

Availability of access information

By contacting the study representative